Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT01075425Phase 1Completed
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Myelogenous Leukemia+1 more
Studychair

Research Network

Collaboration Network

47 collaborators·46 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Beata Holkova, MD

Massey Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score44%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Qifa Liu

Nanfang Hospital, Southern Medical University

Moderately Similar
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score30%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Moderately Similar
15 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute+1 more
Similarity Score30%

Yves Beguin, MD, PhD

CHU-ULg

Moderately Similar
7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+1 more
Similarity Score30%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes
Similarity Score23%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Jorge E Cortes, MD

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score23%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes
Similarity Score23%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01075425Phase 1StudyChair

Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Myelogenous Leukemia+1 more
Completed

All 1 trials loaded